Paragon Private Wealth Management LLC Sells 1,243 Shares of Axon Enterprise, Inc $AXON

Paragon Private Wealth Management LLC decreased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 73.2% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 456 shares of the biotechnology company’s stock after selling 1,243 shares during the period. Paragon Private Wealth Management LLC’s holdings in Axon Enterprise were worth $256,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise in the 4th quarter worth approximately $28,000. Keating Financial Advisory Services Inc. purchased a new stake in shares of Axon Enterprise during the second quarter valued at approximately $31,000. AlphaCentric Advisors LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $34,000. Darwin Wealth Management LLC bought a new stake in Axon Enterprise during the second quarter worth $37,000. Finally, Strive Financial Group LLC bought a new stake in Axon Enterprise during the fourth quarter worth $41,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of recent analyst reports. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Citizens Jmp reiterated a “market outperform” rating and set a $700.00 target price on shares of Axon Enterprise in a research note on Thursday, June 25th. Argus boosted their price target on shares of Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday. Piper Sandler increased their price target on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Finally, Needham & Company LLC restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $721.57.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $538.15 on Friday. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $792.16. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The business’s 50 day simple moving average is $568.46 and its 200 day simple moving average is $486.03. The company has a market cap of $43.72 billion, a price-to-earnings ratio of 223.30, a PEG ratio of 8.23 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The business’s revenue for the quarter was up 35.3% on a year-over-year basis. During the same period last year, the business posted $2.12 earnings per share. Sell-side analysts forecast that Axon Enterprise, Inc will post 2.04 EPS for the current year.

Insider Transactions at Axon Enterprise

In related news, CEO Patrick Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Tuesday, July 7th. The stock was sold at an average price of $643.79, for a total value of $6,437,900.00. Following the completion of the sale, the chief executive officer owned 3,040,997 shares of the company’s stock, valued at approximately $1,957,763,458.63. This trade represents a 0.33% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $574.43, for a total value of $9,636,063.25. Following the completion of the sale, the president owned 296,974 shares in the company, valued at $170,590,774.82. This represents a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 56,380 shares of company stock worth $32,582,366. 4.20% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.